Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trial

Higher doses of radiation to the immune system were associated with worse PFS in this secondary analysis of the PET-Plan trial. The omission of elective nodal irradiation did not influence EDRIC. MBD could potentially suffice as a surrogate for EDRIC, as it is more readily available and requires fewer calculations. Future trials should aim to refine existing models and investigate ways to reduce EDRIC to limit its effects in patients undergoing cCRT for locally advanced NSCLC.

Authors

Institutions

Publication Details

Journal
Radiotherapy and Oncology
Published
2025-04-25
DOI
https://doi.org/10.1016/j.radonc.2025.110907
Citations
2
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trial

Jörg Sahlmann, Matthias Miederer, Abdelkhalek Hammi, Harald Binder et al.
2 citations
Radiotherapy and Oncology
Lung Cancer Diagnosis and Treatment
3.04
article

Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trial

Jörg Sahlmann, Matthias Miederer, Abdelkhalek Hammi, Harald Binder, Eleni Gkika, Cas Stefaan Dejonckheere, Michael Tobias Engelhart, Alexander Brose, Anca-Ligia Grosu, J. König, Andreas Rimner, Markus Hecht, Cornelius F. Waller, Younèss Nour, Sonja Adebahr, Tanja Schimek‐Jasch, Severin Schmid, Ursula Nestle, Simeon Ari Barth
article en
2 citations

Abstract

Higher doses of radiation to the immune system were associated with worse PFS in this secondary analysis of the PET-Plan trial. The omission of elective nodal irradiation did not influence EDRIC. MBD could potentially suffice as a surrogate for EDRIC, as it is more readily available and requires fewer calculations. Future trials should aim to refine existing models and investigate ways to reduce EDRIC to limit its effects in patients undergoing cCRT for locally advanced NSCLC.

Radiotherapy and OncologyVol. 208
University of Freiburg (DE), Universitätsklinikum Gießen und Marburg (DE), University Hospital Bonn (DE), University Medical Center Freiburg (DE), Saarland University (DE)
Deutsche Krebshilfe
Good health and well-being
Openalex Percentile: Top 10%
Lung Cancer Diagnosis and Treatment
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.